# A Trial That Compare Two Treatments in Newly Diagnosed Myeloma Patients Not Eligible for Transplant

> **NCT04096066** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Fondazione EMN Italy Onlus** · enrollment: 84 (actual)

## Conditions studied

- Multiple Myeloma
- New Diagnosis Tumor

## Interventions

- **DRUG:** Carfilzomib
- **DRUG:** Lenalidomide
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT04096066
- **Lead sponsor:** Fondazione EMN Italy Onlus
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-07-01
- **Primary completion:** 2026-01-01
- **Final completion:** 2026-01-01
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2025-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04096066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04096066, "A Trial That Compare Two Treatments in Newly Diagnosed Myeloma Patients Not Eligible for Transplant". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04096066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*